TN2009000240A1 - Renin inhibitors for the prevention and treatment of hypertension in obese patients - Google Patents
Renin inhibitors for the prevention and treatment of hypertension in obese patientsInfo
- Publication number
- TN2009000240A1 TN2009000240A1 TNP2009000240A TN2009000240A TN2009000240A1 TN 2009000240 A1 TN2009000240 A1 TN 2009000240A1 TN P2009000240 A TNP2009000240 A TN P2009000240A TN 2009000240 A TN2009000240 A TN 2009000240A TN 2009000240 A1 TN2009000240 A1 TN 2009000240A1
- Authority
- TN
- Tunisia
- Prior art keywords
- hypertension
- prevention
- treatment
- obese patients
- renin inhibitors
- Prior art date
Links
- 239000002461 renin inhibitor Substances 0.000 title abstract 3
- 229940086526 renin-inhibitors Drugs 0.000 title abstract 3
- 206010020772 Hypertension Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- UXOWGYHJODZGMF-QORCZRPOSA-N Aliskiren Chemical compound COCCCOC1=CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)=CC=C1OC UXOWGYHJODZGMF-QORCZRPOSA-N 0.000 abstract 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 abstract 1
- 229960004601 aliskiren Drugs 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 239000002934 diuretic Substances 0.000 abstract 1
- 230000001882 diuretic effect Effects 0.000 abstract 1
- 229960002003 hydrochlorothiazide Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87018006P | 2006-12-15 | 2006-12-15 | |
| PCT/US2007/087322 WO2008074001A1 (en) | 2006-12-15 | 2007-12-13 | Renin inhibitors for the prevention and treatment of hypertension in obese patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2009000240A1 true TN2009000240A1 (en) | 2010-10-18 |
Family
ID=39186152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2009000240A TN2009000240A1 (en) | 2006-12-15 | 2009-06-12 | Renin inhibitors for the prevention and treatment of hypertension in obese patients |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20100029775A1 (https=) |
| EP (1) | EP2094259A1 (https=) |
| JP (1) | JP2010513300A (https=) |
| KR (1) | KR20090090384A (https=) |
| CN (1) | CN101583355A (https=) |
| AU (1) | AU2007333095B2 (https=) |
| BR (1) | BRPI0721167A2 (https=) |
| CA (1) | CA2672579A1 (https=) |
| CL (1) | CL2007003628A1 (https=) |
| IL (1) | IL198876A0 (https=) |
| MA (1) | MA31003B1 (https=) |
| MX (1) | MX2009006340A (https=) |
| NO (1) | NO20092597L (https=) |
| RU (1) | RU2009126741A (https=) |
| TN (1) | TN2009000240A1 (https=) |
| TW (1) | TW200831071A (https=) |
| WO (1) | WO2008074001A1 (https=) |
| ZA (1) | ZA200903442B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2143425A1 (de) * | 2008-07-11 | 2010-01-13 | Ratiopharm GmbH | Direktverpresste Aliskiren-Tabletten |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8168616B1 (en) * | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
| AR047880A1 (es) * | 2004-02-17 | 2006-03-01 | Novartis Ag | COMBINACIoN DE UN INHIBIDOR DE RENINA Y DIURÉTICOS |
| NZ549535A (en) * | 2004-03-17 | 2010-11-26 | Novartis Ag | Use of aliskiren for treating renal and other disorders |
| WO2007047351A2 (en) * | 2005-10-13 | 2007-04-26 | Orexigen Therapeutics, Inc. | Methods for treating hypertension in overweight and obese individuals |
| US20070293552A1 (en) * | 2006-06-15 | 2007-12-20 | Gorczynski Richard J | Antihypertensive therapy method |
-
2007
- 2007-12-13 KR KR1020097014655A patent/KR20090090384A/ko not_active Withdrawn
- 2007-12-13 AU AU2007333095A patent/AU2007333095B2/en not_active Ceased
- 2007-12-13 WO PCT/US2007/087322 patent/WO2008074001A1/en not_active Ceased
- 2007-12-13 MX MX2009006340A patent/MX2009006340A/es not_active Application Discontinuation
- 2007-12-13 BR BRPI0721167-8A patent/BRPI0721167A2/pt not_active IP Right Cessation
- 2007-12-13 JP JP2009541572A patent/JP2010513300A/ja not_active Withdrawn
- 2007-12-13 US US12/519,189 patent/US20100029775A1/en not_active Abandoned
- 2007-12-13 EP EP07865611A patent/EP2094259A1/en not_active Withdrawn
- 2007-12-13 RU RU2009126741/15A patent/RU2009126741A/ru not_active Application Discontinuation
- 2007-12-13 CA CA002672579A patent/CA2672579A1/en not_active Abandoned
- 2007-12-13 CN CNA2007800499179A patent/CN101583355A/zh active Pending
- 2007-12-14 CL CL200703628A patent/CL2007003628A1/es unknown
- 2007-12-14 TW TW096148110A patent/TW200831071A/zh unknown
-
2009
- 2009-05-19 ZA ZA200903442A patent/ZA200903442B/xx unknown
- 2009-05-21 IL IL198876A patent/IL198876A0/en unknown
- 2009-06-12 TN TNP2009000240A patent/TN2009000240A1/fr unknown
- 2009-06-17 MA MA32007A patent/MA31003B1/fr unknown
- 2009-07-08 NO NO20092597A patent/NO20092597L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MX2009006340A (es) | 2009-06-23 |
| AU2007333095B2 (en) | 2011-03-24 |
| NO20092597L (no) | 2009-07-13 |
| WO2008074001A1 (en) | 2008-06-19 |
| CL2007003628A1 (es) | 2008-07-18 |
| BRPI0721167A2 (pt) | 2014-03-18 |
| KR20090090384A (ko) | 2009-08-25 |
| RU2009126741A (ru) | 2011-01-20 |
| IL198876A0 (en) | 2010-02-17 |
| CN101583355A (zh) | 2009-11-18 |
| EP2094259A1 (en) | 2009-09-02 |
| US20100029775A1 (en) | 2010-02-04 |
| JP2010513300A (ja) | 2010-04-30 |
| CA2672579A1 (en) | 2008-06-19 |
| MA31003B1 (fr) | 2009-12-01 |
| TW200831071A (en) | 2008-08-01 |
| AU2007333095A1 (en) | 2008-06-19 |
| ZA200903442B (en) | 2010-05-26 |
| WO2008074001A8 (en) | 2009-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005023179A3 (en) | Combination methods of treating cancer | |
| WO2007056244A3 (en) | Methods of using saha and erlotinib for treating cancer | |
| MX2009004984A (es) | Metodos para conservar la funcion renal utilizando inhibidores de oxidoreductasa de xantina. | |
| ZA200806778B (en) | N-Hydroxyacrylamide compounds | |
| WO2007056232A3 (en) | Methods of using saha and bortezomib for treating cancer | |
| WO2011123719A3 (en) | Use of faah inhibitors for treating abdominal, visceral and pelvic pain | |
| WO2008024439A3 (en) | 4-aminoquinazoline derivatives and methods of use thereof | |
| MX2009010946A (es) | Uso de un inhibidor del factor de necrosis tumoral alfa mas una antihistamina para tratar rinitis alergica y conjuntivitis alergica. | |
| MX2008011633A (es) | Aminoquinolonas como inhibidores de gsk-3. | |
| WO2008057456A3 (en) | Methods of using saha and bortezomib for treating multiple myeloma | |
| MY154591A (en) | Therapeutic compositions comprising a specific endothelin receptor antagonist and a pde5 inhibitor | |
| MX2012009600A (es) | Metodo para estabilizar daño de articulacion en sujetos utilizando inhibidores de xantina oxidoreductasa. | |
| IL178100A0 (en) | 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension | |
| EA200970164A1 (ru) | Ингибиторы каспазы на основе пиридазинонового каркаса | |
| WO2007019153A3 (en) | Methods for treating hypertension | |
| MX2007004020A (es) | Uso de inhibidores de renina para la prevencion o tratamiento de disfuncion diastolica o falla cardiaca diastolica. | |
| WO2007097980A3 (en) | Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy | |
| TN2009000240A1 (en) | Renin inhibitors for the prevention and treatment of hypertension in obese patients | |
| TNSN08383A1 (en) | Renin inhibitors for the treatment of hypertension | |
| WO2009148600A3 (en) | Deuterated lysine-based compounds | |
| WO2007044325A3 (en) | Apoe4 domain interaction inhibitors and methods of use thereof | |
| WO2007136615A3 (en) | Combination cancer therapy | |
| UA96736C2 (ru) | Ингибиторы pi3k для лечения эндометриоза | |
| HK1132674A (en) | Renin inhibitors for the prevention and treatment of hypertension in obese patients | |
| WO2007120669A8 (en) | Tetrahalogenated compounds useful as inhibitors of angiogenesis |